Pharmaceutical formulations of nitrite and uses thereof
The present invention relates to pharmaceutical compositions of nitrites such as inorganic nitrites, or any pharmaceutically acceptable salts, solvates, or prodrugs thereof, and the medical use of these compositions. The pharmaceutical compositions, which can be formulated for oral administration, can provide immediate release or extended release of the nitrite ion (NO 2 − ). The pharmaceutical compositions of the invention are useful, for example, for the treatment of chronic tissue ischemia.
1. A method for treating peripheral neuropathy in a human, the method comprising orally administering two times per day for at least three days a solid, sustained release pharmaceutical composition comprising about 40 mg of sodium nitrite, or a pharmaceutically acceptable salt thereof, and a binding agent, wherein the pharmaceutical composition is coated with an enteric coating.
2. The method of claim 1 , wherein the sodium nitrite is not substantially released in the stomach of the human.
3. The method of claim 1 , wherein the sustained release pharmaceutical composition is administered for at least seven days.
4. The method of claim 1 , wherein the sustained release pharmaceutical composition is administered for at least ten days.
5. The method of claim 1 , wherein the binding agent is sucrose, glucose, sorbitol, acacia, alginic acid, sodium alginate, gelatin, starch, pregelatinized starch, microcrystalline cellulose, magnesium aluminum silicate, carboxymethylcellulose sodium, methylcellulose, hydroxypropyl methylcellulose, ethylcellulose, polyvinylpyrrolidone, or polyethlene glycol.
6. The method of claim 5 , wherein the binding agent is hydroxypropyl methylcellulose, microcrystalline cellulose, or polyvinyl pyrrolidone.
7. The method of claim 1 , wherein the enteric coating comprises a polymer selected from cellulose acetate phthalate, hydroxypropylmethylcellulose acetate succinate, methacrylate acid copolymers, cellulose acetate trimellitate, polyvinyl acetate phthalate, hydroxyethylcellulose phthalate, and hydroxypropyl methylcellulose phthalate.